Sign In
Buy LLY
$1,129.13
+11.87 (+1.06%)
At Close: Jun 25, 2026
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
06:45am, Thursday, 25'th Jun 2026
A new Medicare pathway, the Medicare GLP-1 Bridge program, makes Lilly's obesity medicines – a daily pill or the number 1 most prescribed injectable – accessible to eligible Medicare Part D patien
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
08:45am, Wednesday, 24'th Jun 2026
INDIANAPOLIS, June 24, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Centessa Pharmaceuticals plc. Centessa is a clinical-stage
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
09:38pm, Tuesday, 23'rd Jun 2026
Abbisko Cayman said on Wednesday that its Shanghai-based unit Abbisko Therapeutics has entered into a strategic research collaboration and license agreement with Eli Lilly.
Trump visits Mack Trucks plant in battleground Pennsylvania district to tout economic agenda as midterms loom
09:36pm, Tuesday, 23'rd Jun 2026
Donald Trump visited the Mack Trucks facility in Macungie, Pennsylvania, to promote his economic agenda in a key battleground district ahead of the midterm elections.
Biotech's Silent Resurgence (5-Year Base Breakout)
05:21pm, Tuesday, 23'rd Jun 2026
The biotech sector's fundamentals are shifting rapidly-and the smartest money on Wall Street is already quietly rotating into the sector.
How Eli Lilly Became a $1 Trillion Company
01:34pm, Tuesday, 23'rd Jun 2026
Mounjaro and Zepbound turned Eli Lilly into a trillion-dollar pharmaceutical giant. But every blockbuster drug eventually faces competition.
Eli Lilly says Trump pricing policy will affect obesity drug launches in Europe
12:10pm, Tuesday, 23'rd Jun 2026
Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of 2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market as it has done i
Fund manager names 3 non-AI stocks to own as Intel, AMD sink amid broader tech rout
11:51am, Tuesday, 23'rd Jun 2026
The tech sector is experiencing a sharp global sell-off today, dragging down chipmakers like Intel, AMD, Micron, and even the artificial intelligence (AI) darling – Nvidia. What's driving this weakn
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
10:01am, Tuesday, 23'rd Jun 2026
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
3 Monster Stocks to Hold for the Next 10 Years
06:05am, Tuesday, 23'rd Jun 2026
These players sell market-leading products and are tackling growth industries. Holding for several years, rather than a short period, allows investors to fully benefit from each company's story.
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk
08:15pm, Monday, 22'nd Jun 2026
Viking Therapeutics has a weight-loss program that looks to be competitive with medicines already on the market. It's unclear how its candidate compares to competing programs that are still in clinica
Eli Lilly vs Pfizer: One Owns the Obesity Market Today, The Other Paid to Compete Tomorrow
04:02pm, Monday, 22'nd Jun 2026
Eli Lilly (NYSE: LLY | LLY Price Prediction) and Pfizer (NYSE: PFE) just delivered Q1 2026 results that read like two different chapters of the same drug industry.
Lilly declares third-quarter 2026 dividend
12:00pm, Monday, 22'nd Jun 2026
Lilly declares third-quarter 2026 dividend PR Newswire INDIANAPOLIS, June 22, 2026
Lilly declares third-quarter 2026 dividend
11:00am, Monday, 22'nd Jun 2026
INDIANAPOLIS, June 22, 2026 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2026 of $1.73 per share on outstanding common s
13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now.
03:52am, Monday, 22'nd Jun 2026
Want to really go big? One megacap stock offers an especially attractive risk-reward proposition.
